Virus specific cell-mediated immunity may play a role in controlling reactivated human herpesvirus 6B in patients under measles induced immunosuppression

Journal of Medical Virology

Volumn 86, Issue 4, 2014, Pages 658-665

  Kumagai, Takuji ^a   Yoshikawa, Tetsushi ^b   Shiraki, Kimiyasu ^c   Yoshida, Mariko ^d   Nakayama, Tetsuo ^e   Ihira, Masaru ^b   Asano, Yoshizo ^b,f  

^a Kumagai Pediatric Clinic   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e KITASATO UNIVERSITY   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cell mediated immunity; Human herpesvirus 6B; Lymphocyte proliferation; Measles

Indexed keywords

CELL-MEDIATED IMMUNITY; HUMAN HERPESVIRUS 6B; LYMPHOCYTE PROLIFERATION; MEASLES;

CELL PROLIFERATION; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFANT; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MEASLES; ROSEOLOVIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 84893781632     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23862     Document Type: Article

References (25)

1. Alvarez-Lafuente R, Martin-Estefania C, de las Heras V, Castrillo C, Cour I, Picazo JJ, Varela De Seijas E, Arroyo R. 2002. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand 105:95-99.
2. Asano Y, Yoshikawa T, Suga S, Yazaki T, Hata T, Nagai T, Kajita Y, Ozaki T, Yoshida S. 1989. Viremia and neutralizing antibody response in infants with exanthem subitum. J Pediatr 114:535-539.
3. Asano Y, Yoshikawa T, Suga S, Yazaki T, Ozaki T, Saito Y, Hatano Y, Takahashi M. 1990. Enzyme-linked immunosorbent assay for detection of IgG antibody to human herpesvirus 6. J Med Virol 32:119-123.
4. Avota E, Harms H, Schneider-Schaulies S. 2006. Measles virus induces expression of SIP110, a constitutively membrane clustered lipid phosphatase, which inhibits T cell proliferation. Cell Microbiol 8:1826-1839.
5. Avota E, Gassert E, Schneider-Schaulies S. 2010. Measles virus-induced immunosuppression: From effectors to mechanisms. Med Microbiol Immunol 199:227-237.
6. Caserta MT, McDermott MP, Dewhurst S, Schnabel K, Carnahan JA, Gilbert L, Lathan G, Lofthus GK, Hall CB. 2004. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J Pediatr 145:478-484.
7. Cuende JI, Ruiz J, Civeira MP, Prieto J. 1994. High prevalence of HHV-6 DNA in peripheral blood mononuclear cells of healthy individuals detected by nested-PCR. J Med Virol 43:115-118.
8. Kahlon J, Lakeman FD, Ackermann M, Whitley RJ. 1986. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin Microbiol 23:725-730.
9. Kobune F, Sakata H, Sugiura A. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 64:700-705.
10. Kumagai T, Chiba Y, Wataya Y, Hanazono H, Chiba S, Nakao T. 1980. Development and characteristics of the cellular immune response to infection with varicella-zoster virus. J Infect Dis 141:7-13.
11. Kumagai T, Kamada M, Igarashi C, Yuri K, Furukawa H, Chiba S, Kojima H, Saito A, Okui T, Yano S. 1999. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure. J Infect Dis 180:834-837.
12. Kumagai T, Yoshikawa T, Yoshida M, Okui T, Ihira M, Nagata N, Yano S, Shiraki K, Yamada M, Ichihara K, Asano Y. 2006. Time course characteristics of human herpesvirus 6 specific cellular immune response and natural killer cell activity in patients with exanthema subitum. J Med Virol 78:792-799.
13. Martin ML, Palmer EL. 1973. Complement-fixing antigens produced by varicella-zoster virus in tissue culture. Appl Microbiol 26:410-416.
14. Miyamura K, Sato TA, Sakae K, Kato N, Ogino T, Yashima T, Sasagawa A, Chikahira M, Itagaki A, Katsuki K, Matsunaga Y, Utagawa E, Takeda N, Inouye S, Yamazaki S. 1997. Comparison of gelatin particle agglutination and hemagglutination inhibition tests for measles seroepidemiology studies. Arch Virol 142:1963-1970.
15. Mori Y, Dhepakson P, Shimamoto T, Ueda K, Gomi Y, Tani H, Matsuura Y, Yamanishi K. 2000. Expression of human herpesvirus 6B rep within infected cells and binding of its gene product to the TATA-binding protein in vitro and in vivo. J Virol 74:6096-6104.
16. Motulsky H. 1995. Intuitive biostatistics. New York and Oxford: Oxford University Press, Inc., 260 p.
17. Ohashi M, Sugata K, Ihira M, Asano Y, Egawa H, Takada Y, Uemoto S, Yoshikawa T. 2008. Human herpesvirus 6 infection in adult living related liver transplant recipients. Liver Transpl 14:100-109.
18. Suga S, Yoshikawa T, Asano Y, Yazaki T, Yoshida S. 1990. Simultaneous infection with human herpesvirus-6 and measles virus in infants. J Med Virol 31:306-311.
19. Suga S, Yoshikawa T, Asano Y, Nakashima T, Kobayashi I, Yazaki T. 1992. Activation of human herpesvirus-6 in children with acute measles. J Med Virol 38:278-282.
20. Takahashi K, Segal E, Kondo T, Mukai T, Moriyama M, Takahashi M, Yamanishi K. 1992. Interferon and natural killer cell activity in patients with exanthem subitum. Pediatr Infect Dis J 11:369-373.
21. Tanaka N, Kimura H, Hoshino Y, Kato K, Yoshikawa T, Asano Y, Horibe K, Kojima S, Morishima T. 2000. Monitoring four herpesviruses in unrelated cord blood transplantation. Bone Marrow Transplant 26:1193-1197.
22. Tsukazaki T, Yoshida M, Namba H, Yamada M, Shimizu N, Nii S. 1998. Development of a dot blot neutralizing assay for HHV-6 and HHV-7 using specific monoclonal antibodies. J Virol Methods 73:141-149.
23. Yoshikawa T, Suga S, Asano Y, Yazaki T, Kodama H, Ozaki T. 1989. Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals. Pediatrics 84:675-677.
24. Zweerink HJ, Corey L. 1982. Virus-specific antibodies in sera from patients with genital herpes simplex virus infection. Infect Immun 37:413-421.
25. Zweerink HJ, Stanton LW. 1981. Immune response to herpes simplex virus infections: Virus-specific antibodies in sera from patients with recurrent facial infections. Infect Immun 31:624-630.